UBS AM’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Buy |
143,611
+7,914
| +6% | +$508K | ﹤0.01% | 1206 |
|
|
2026
Q1 | $7.65M | Buy |
135,697
+4,138
| +3% | +$269K | ﹤0.01% | 1350 |
|
|
2025
Q4 | $10.5M | Sell |
131,559
-407
| -0.3% | -$27.3K | ﹤0.01% | 1098 |
|
|
2025
Q3 | $6.43M | Sell |
131,966
-81,943
| -38% | -$5.07M | ﹤0.01% | 1250 |
|
|
2025
Q2 | $16M | Buy |
213,909
+57,771
| +37% | +$3.82M | ﹤0.01% | 1138 |
|
|
2025
Q1 | $9.92M | Buy |
156,138
+9,051
| +6% | +$616K | ﹤0.01% | 1228 |
|
|
2024
Q4 | $11.5M | Buy |
147,087
+18,964
| +15% | +$1.52M | ﹤0.01% | 1187 |
|
|
2024
Q3 | $10.3M | Sell |
128,123
-3,643
| -3% | -$294K | ﹤0.01% | 1202 |
|
|
2024
Q2 | $10.9M | Buy |
131,766
+63,189
| +92% | +$5.56M | ﹤0.01% | 1093 |
|
|
2024
Q1 | $5.85M | Buy |
68,577
+7,885
| +13% | +$619K | ﹤0.01% | 1192 |
|
|
2023
Q4 | $5.19M | Sell |
60,692
-1,332
| -2% | -$115K | ﹤0.01% | 1227 |
|
|
2023
Q3 | $5.56M | Sell |
62,024
-4,852
| -7% | -$433K | ﹤0.01% | 1168 |
|
|
2023
Q2 | $5.53M | Hold |
66,876
| – | – | ﹤0.01% | 1186 |
|
|
2023
Q1 | $5.53M | Buy |
66,876
+9,191
| +16% | +$744K | ﹤0.01% | 1186 |
|
|
2022
Q4 | $4.54M | Buy |
57,685
+3,631
| +7% | +$292K | ﹤0.01% | 1202 |
|
|
2022
Q3 | $4M | Sell |
54,054
-7,170
| -12% | -$515K | ﹤0.01% | 1277 |
|
|
2022
Q2 | $3.99M | Sell |
61,224
-552
| -0.9% | -$32.7K | ﹤0.01% | 1293 |
|
|
2022
Q1 | $3.91M | Buy |
61,776
+411
| +0.7% | +$22.3K | ﹤0.01% | 1462 |
|
|
2021
Q4 | $3.25M | Buy |
61,365
+462
| +0.8% | +$28.1K | ﹤0.01% | 1620 |
|
|
2021
Q3 | $4.3M | Sell |
60,903
-334
| -0.5% | -$21.1K | ﹤0.01% | 1421 |
|
|
2021
Q2 | $4.08M | Sell |
61,237
-21,640
| -26% | -$1.53M | ﹤0.01% | 1469 |
|
|
2021
Q1 | $9.2M | Sell |
82,877
-1,860
| -2% | -$230K | ﹤0.01% | 1112 |
|
|
2020
Q4 | $10.1M | Buy |
84,737
+19,836
| +31% | +$2.14M | ﹤0.01% | 1048 |
|
|
2020
Q3 | $5.66M | Sell |
64,901
-46,421
| -42% | -$4.06M | ﹤0.01% | 1109 |
|
|
2020
Q2 | $9.97M | Buy |
111,322
+19,636
| +21% | +$1.98M | 0.01% | 909 |
|
|
2020
Q1 | $9.14M | Sell |
91,686
-9,329
| -9% | -$1.01M | 0.01% | 885 |
|
|
2019
Q4 | $11.6M | Sell |
101,015
-6,267
| -6% | -$758K | 0.01% | 902 |
|
|
2019
Q3 | $13.5M | Buy |
107,282
+33,597
| +46% | +$4.26M | 0.01% | 864 |
|
|
2019
Q2 | $8.87M | Buy |
73,685
+34,929
| +90% | +$3.44M | 0.01% | 997 |
|
|
2019
Q1 | $3.39M | Buy |
38,756
+4,622
| +14% | +$420K | ﹤0.01% | 1297 |
|
|
2018
Q4 | $3.42M | Sell |
34,134
-4,931
| -13% | -$518K | ﹤0.01% | 1220 |
|
|
2018
Q3 | $4.48M | Buy |
39,065
+590
| +2% | +$61.1K | ﹤0.01% | 1182 |
|
|
2018
Q2 | $3.45M | Sell |
38,475
-195
| -0.5% | -$16.5K | ﹤0.01% | 1283 |
|
|
2018
Q1 | $2.83M | Buy |
38,670
+4,281
| +12% | +$294K | ﹤0.01% | 1325 |
|
|
2017
Q4 | $2M | Buy |
34,389
+4,300
| +14% | +$226K | ﹤0.01% | 1437 |
|
|
2017
Q3 | $1.35M | Buy |
30,089
+1,936
| +7% | +$80.4K | ﹤0.01% | 1574 |
|
|
2017
Q2 | $1.11M | Buy |
28,153
+742
| +3% | +$30.5K | ﹤0.01% | 1611 |
|
|
2017
Q1 | $1.11M | Buy |
27,411
+6,892
| +34% | +$269K | ﹤0.01% | 1599 |
|
|
2016
Q4 | $825K | Sell |
20,519
-14,742
| -42% | -$556K | ﹤0.01% | 1623 |
|
|
2016
Q3 | $1.28M | Hold |
35,261
| – | – | ﹤0.01% | 1582 |
|
|
2016
Q2 | $1.02M | Buy |
35,261
+5,513
| +19% | +$167K | ﹤0.01% | 1640 |
|
|
2016
Q1 | $1.04M | Sell |
29,748
-7,594
| -20% | -$245K | ﹤0.01% | 1620 |
|
|
2015
Q4 | $1.2M | Buy |
37,342
+5,544
| +17% | +$180K | ﹤0.01% | 1661 |
|
|
2015
Q3 | $1.03M | Buy |
31,798
+8,500
| +36% | +$320K | ﹤0.01% | 1714 |
|
|
2015
Q2 | $964K | Sell |
23,298
-164,752
| -88% | -$6.95M | ﹤0.01% | 1695 |
|
|
2015
Q1 | $8.45M | Sell |
188,050
-42,637
| -18% | -$1.78M | 0.01% | 923 |
|
|
2014
Q4 | $8.63M | Sell |
230,687
-57,062
| -20% | -$2.09M | 0.01% | 910 |
|
|
2014
Q3 | $10M | Buy |
287,749
+190,711
| +197% | +$6.81M | 0.01% | 837 |
|
|
2014
Q2 | $3.42M | Buy |
97,038
+78,440
| +422% | +$2.62M | ﹤0.01% | 1135 |
|
|
2014
Q1 | $606K | Buy |
18,598
+1,200
| +7% | +$45.9K | ﹤0.01% | 1776 |
|
|
2013
Q4 | $733K | Hold |
17,398
| – | – | ﹤0.01% | 1631 |
|
|
2013
Q3 | $694K | Hold |
17,398
| – | – | ﹤0.01% | 1637 |
|
|
2013
Q2 | $719K | Buy |
+17,398
| New | +$704K | ﹤0.01% | 1570 |
|
Other funds holding HAE
AI
UBS AM's HAE Position: Q2 2026 in Review
UBS AM increased its Haemonetics (HAE) stake by 5.8% in Q2 2026, buying an estimated $508K and bringing the position to 143,611 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1206.
UBS AM first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $16M in Q2 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- UBS AM held 143,611 shares of Haemonetics worth $10.8M as of Q2 2026.
- UBS AM bought 7,914 Haemonetics shares in Q2 2026, an estimated $508K.
- Haemonetics made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1206 holding.
- UBS AM first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- UBS AM's Haemonetics position peaked at $16M in Q2 2025.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.